SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ecoscience (ECSC)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: WWS who wrote (118)10/11/1997 6:36:00 PM
From: Steve Harmon  Read Replies (2) of 145
 
Bill,

ECSC had slightly higher revenues than I had in my projected revenues in May. They ended up with $20.8 mil. in revenue for the fiscal year just ended. The AGRO division is where big increases were achieved.

The key to ECSC are the products BIO-BLAST and BIO-SAVE. Those are the products that have the BIG profit margins. Very dissapointing revenue from those two products this past year.

Your gold industry has popped the last couple of weeks. A lot of money is now going into the undervalued micro cap stocks in a big way.

Reduced my CMSI position recently for a small gain(10%) because of the manipulation going on there. Starting to concentrate on a small biotech I have been tracking for over a year called CISTRON BIOTECH-CIST. They recently picked up sponsorship which in my view is all they lacked. At these levels(29 cents), CIST offers a EXTREME VALUE.(They have around 50 cents a share in cash).

Thanks again for the ADSO tip a while back. Made a quick profit on that one. The value at 50 cents was tremendous.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News